In 2016, investment and M&A transactions were very frequent, and the amount of transactions that exceeded tens of millions or even billions of dollars reflected that the medical industry is in a booming stage of development.
Below, the author will give you a review of the major events in the medical machinery industry and investment circle in 2016.
January 8, 2016
Thermo Fisher acquires the world's most cattle gene chip company with a market value of over 50%
Thermo Fisher announced that it has approved the board of directors of the company to acquire a well-known chip manufacturer, Affymetrix (Affymetrix), for a total of $1.3 billion in cash at a price of $14 per share. Effie matrix). The acquisition will strengthen Thermo Fisher's leadership in the biological sciences and provide new clinical research opportunities and application markets for its genetics. Affymetrix's products will help the company rapidly expand the market for flow cytometry, and with the help of Thermo Fisher's global business contacts, these products will serve more customers.
February 2, 2016
Stryker acquires SageProducts for $2.78 billion
Stryker Corp. The company announced the acquisition of SaGEProducts from MADIson Dearborn Partners for a total of $2.78 billion in cash to enhance the provision of a full range of medical device facilities for more patients. The acquired Sage company provides oral medical care, skin regeneration and protection, patient care, installation and positioning of foot medical device services. The two companies are fully complementary in the production of the products, especially in the field of urgently needed infections.
February 16, 2016
Stryker will acquire defibrillator manufacturers for $1.28 billion
Stryker Corp, a famous American orthopaedic medical company, announced that it will acquire defibrillator manufacturer Physio-Control International Inc. from private equity firm Bain Capital for $1.28 billion in cash. The transaction is expected to be completed early in the second quarter and will help Stryker's earnings growth.
March 6, 2016
Mindray announced privatization, the company delisted from the New York Stock Exchange
Listed on the NYSE in the US, one of the Big Three Chinese Medical Equipment Mindray Medical (Mindray Medical International) announced that it has completed 3.3 billion US dollars worth of privatization transactions. The completion of the $28 per share transaction means that Mindray Medical’s stock MR on the New York Stock Exchange will terminate the transaction.
Anesthesia Medical Co., Ltd. , https://www.honestymed.com